Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Spike Protein IgG Antibody”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)Study completedNCT04566276
What this trial is testing

ChulaCov19 Vaccine in Healthy Adults

Who this might be right for
COVID-19 VaccineSafety Issues
Chulalongkorn University 192
Testing effectiveness (Phase 2)Active Not RecruitingNCT05654506
What this trial is testing

Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits

Who this might be right for
Proliferative Glomerulonephritis With Monoclonal IgG Deposits
Mayo Clinic 40
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Not applicableWithdrawnNCT05476822
What this trial is testing

Profiling Spike Protein Antibody Response Post COVID-19 Booster

Who this might be right for
COVID-19 BoosterSpike Protein IgG Antibody
David Grant U.S. Air Force Medical Center